Physician

Kirsten Marie Leu, M.D.

According to 2025 Medicare claims, Kirsten Leu, M.D. (NPI: 1467432344) practices medical oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY WEST, PC (NPI: 1932178530; TIN: 470754790) and primary practice location at 68114-4108. Leu is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Maple ACO LLC (ACO ID: A5401), Main Street Rural Health Hawthorn ACO LLC (ACO ID: A5438), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Leu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 441 traditional Medicare patients, billed 85,245 HCPCS/CPT codes, and received $1,029,906 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,473 prescription claims across 239 beneficiaries totaling $986,606 in drug costs, led by Verzenio (Abemaciclib). 2022 DME data shows 11 claims. Open Payments data shows 17 records totaling $389,623. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $511,055 to $1,029,906. Similarly, Part D prescription costs have moved sharply higher in recent years, from $234,211 to $986,606. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	388	56,055	$511,055
2016	396	54,343	$783,029
2017	432	74,441	$1,044,211
2018	457	69,865	$1,177,561
2019	409	60,438	$978,760
2020	513	66,457	$1,147,282
2021	516	82,114	$1,240,038
2022	532	79,983	$1,216,608
2023	592	125,220	$2,087,924
2024	441	85,245	$1,029,906

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	73	482	$234,211
2016	88	586	$268,236
2017	104	603	$254,823
2018	113	672	$214,141
2019	123	847	$200,822
2020	139	918	$181,610
2021	150	943	$656,720
2022	185	987	$602,780
2023	198	1,122	$831,000
2024	239	1,473	$986,606

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$169
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$663
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	278	584	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	128	144	$12
96375	Injection of additional new drug or substance into vein	51	280	$11
80053	Blood test, comprehensive group of blood chemicals	58	185	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	59	241	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	50	1,400	$763,655
Eliquis	Apixaban	45	1,565	$31,479
Imatinib Mesylate	Imatinib Mesylate	42	1,620	$29,180
Letrozole	Letrozole	250	16,324	$4,413
Anastrozole	Anastrozole	221	16,860	$3,614

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$152	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$389,471	Nebraska Methodist Hospital
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kirsten Marie Leu, M.D.?

Tedicare shows public-source Medicare data for Kirsten Marie Leu, M.D. (NPI 1467432344), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kirsten Marie Leu, M.D. have ACO affiliation data?

Kirsten Marie Leu, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Maple ACO LLC (MSSP, ACO ID A5401), Main Street Rural Health Hawthorn ACO LLC (MSSP, ACO ID A5438), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Kirsten Marie Leu, M.D.?

Kirsten Marie Leu, M.D. is linked to ONCOLOGY HEMATOLOGY WEST, PC (billing NPI 1932178530) in the available physician profile data.

Does Kirsten Marie Leu, M.D. have Open Payments data?

Kirsten Marie Leu, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.